Pediatric Kidney Transplantation

Transplantation in children is one of the best options to treat renal failure. Nearly half of children who have received transplants have a functioning kidney graft 14 years after transplantation. Preemptive transplantation is optimal treatment of pediatric ESRD for maintaining growth and development of children. Unfortunately, the other half have returned to dialysis and require a second transplant during childhood or adolescence. In some cases, the transplanted kidney can be rejected due by the recipient’s immune system. In a recent research, it is explained that over the last 25 years the improvements in therapy have reduced the risk of early acute rejection and graft loss, but the long term results in terms of graft survival and morbidity require search for new immunosuppressive regimens. Tolerance of the graft and reducing the side effects are the challenges for improving the outcome of children with a grafted kidney.

  • Track 1-1 Immunosuppressive Medications for Transplantation
  • Track 2-2 Challenges and Perspectives
  • Track 3-3 Causes of Death after Transplantation
  • Track 4-4 Recurrent Diseases after transplantation
  • Track 5-5 Growth after Renal Transplantation
  • Track 6-6 Incidence of Obesity
  • Track 7-7 Transplant Outcomes
  • Track 8-8 Trends in Pediatric Kidney Transplantation
  • Track 9-9 Pre-emptive transplantation
  • Track 10-10 Short and long-term complications
  • Track 11-11 Acute Rejection of Graft
  • Track 12-12 Post-transplant hypertension
  • Track 13-13 Post-transplant Infection
  • Track 14-14 Chronic Allograft Nephropathy
  • Track 15-15 Post-Transplant Lymphoproliferative Disease

Related Conference of Nephrology